Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication
- PMID: 21553812
- PMCID: PMC3124649
- DOI: 10.1021/jm200153p
Thiazolides as novel antiviral agents. 1. Inhibition of hepatitis B virus replication
Abstract
We report the syntheses and activities of a wide range of thiazolides [viz., 2-hydroxyaroyl-N-(thiazol-2-yl)amides] against hepatitis B virus replication, with QSAR analysis of our results. The prototypical thiazolide, nitazoxanide [2-hydroxybenzoyl-N-(5-nitrothiazol-2-yl)amide, NTZ] 1 is a broad spectrum antiinfective agent effective against anaerobic bacteria, viruses, and parasites. By contrast, 2-hydroxybenzoyl-N-(5-chlorothiazol-2-yl)amide 3 is a novel, potent, and selective inhibitor of hepatitis B replication (EC(50) = 0.33 μm) but is inactive against anaerobes. Several 4'- and 5'-substituted thiazolides show good activity against HBV; by contrast, some related salicyloylanilides show a narrower spectrum of activity. The ADME properties of 3 are similar to 1; viz., the O-acetate is an effective prodrug, and the O-aryl glucuronide is a major metabolite. The QSAR study shows a good correlation of observed EC(90) for intracellular virions with thiazolide structural parameters. Finally we discuss the mechanism of action of thiazolides in relation to the present results.
Figures
References
-
- Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J. Hepatol. 2009;50:805–816. - PubMed
-
- Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970:695–698. - PubMed
- Summers J, O’Connell A, Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Nat. Acad. Sci. USA. 1975;72:4597–4601. - PMC - PubMed
-
- Blumberg BS. Australia Antigen and the Biology of Hepatitis B. Science. 1977;197:17–25. - PubMed
-
- Poland GA. Evaluating existing recommendations for hepatitis A and B vaccination. Am. J. Med. 2005;118(10A):16S–20S. - PubMed
- Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann. Intern. Med. 2001;135:796–800. - PubMed
-
- Kohlstaedt LA, Wang J, Friedman JM, Rice PA, Steitz TA. Crystal structure at 3.5Å resolution of HIV reverse transcriptase complexed with an inhibitor. Science. 1992;256:1783–1790. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
